


Immunogenicity risk assessment of synthetic peptide drugs and their impurities
Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes
Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes